Major Depression

The US Food and Drug Administration (FDA) has rejected Alkermes’ New Drug Application for ALKS 5461, a proposed adjunctive treatment for major depressive disorder, citing the need for additional clinical data exhibiting its effectiveness.

Articles

The US Food and Drug Administration (FDA) has rejected Alkermes’ New Drug Application for ALKS 5461, a proposed adjunctive treatment for major depressive disorder, citing the need for additional clinical data exhibiting its effectiveness.

When a teen is diagnosed with depression, it's normal for parents to feel overwhelmed and to search for information about which treatment options are best, doctors write in a new patient resource published January 28 online in JAMA Pediatrics.

Having post-traumatic stress disorder (PTSD), depression treated with antidepressants, or mental illness in general is linked with an increased risk of rapid eye movement (REM) sleep behavior disorder, according to a study published online in Neurology.

A new cohort study confirmed a previously reported association between treatment with antidepressants and hip fracture in older adults, but it contained a twist.

Vladimir Maletic, MD, MS

Psych Congress Steering Committee member Vladimir Maletic, MD, MS, explores the research on the relationship between diet, caloric restriction, and symptoms of depression.

Pages

Blogs

BLOG: This year’s Psych Congress returned, time and again, to the theme of us needing to reconnect with a larger experience of the world in order to find a path out of depression.

BLOG: The logical endpoint of population-based screening for perinatal depression is remission of depression in those who screen positive. Otherwise screening is just an empty endeavor.

BLOG: Michael Pollan, author of The Omnivore’s Dilemma and The Botany of Desire, has turned his spotlight of curiosity onto the subject of psychedelics with his new book How to Change Your Mind.

Pages

Slideshows

Get expert insight on attention-deficit/hyperactivity disorder, major depressive disorder, and addiction, gleaned from presentations at the 2018 Elevate by Psych Congress conference.

Posters

Justin Barnes, PhD; Brandon Coleman, BS; Sylvie Stacy, MD; Tsao-Wei Liang, MD; Stanley Caroff, MD; Greg Salinas, PhD
David G Brock, MD; W. Scott West, MD; Todd Hutton, MD; Kenneth P. Pages, MD; Timothy J. Kane, MD
Kasim Pendi, NA; Arif Pendi, MS; Jahanzeb Ashraf, MS; Kate Wolitzky-Taylor, PhD; Danny Lee, BS, BA; Jeffrey Sugar, MD; Joshua Lee, BS; David Baron, DO, Msed
Suresh Durgam, MD; Changzheng Chen, PhD; Raffaele Migliore, MA; Chandran Prakash, MD, MPH; Michael Thase, MD; Rocsanna Namdar, PharmD

Video

In this video, Mark Zimmerman, MD, discusses severe depression and how it differs from mild and moderate depression, and the signs and treatment of severe depression.

Drs. Raison and Patrick

Psych Congress cochair Charles Raison, MD, recently discussed his research and perspectives in an extensive interview with Rhonda Perciavalle Patrick, PhD, who runs the FoundMyFitness website.

PHQ-9

Saundra Jain, MA, PsyD, LPC, a Psych Congress Steering Commitee member, explains the Patient Health Questionnaire (PHQ-9), the gold standard measurement tool in major depression.

Pages

Audio

Two members of the Psych Congress Steering Committee have been featured on an ABC News podcast which grew out of a newsman's newfound interest in meditation.